Risk of Cardiovascular Mortality in Relation to Optimal Low-Density Lipoprotein Cholesterol Combined with Hypertriglyceridemia: Is There a Difference by Gender?

Annals of Epidemiology

Volumn 21, Issue 11, 2011, Pages 807-814

  Kuklina, Elena V ^a   Keenan, Nora L ^a   Callaghan, William M ^a   Hong, Yuling ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Epidemiology; Hyperlipoproteinemia; Lipids; Risk Factors

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; FEMALE; FOLLOW UP; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 80053497761     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2011.08.004     Document Type: Article

References (29)

1. Sharma R.K., Singh V.N., Reddy H.K. Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk. Vasc Health Risk Manag 2009, 5:793-799.
2. Sarwar N., Sattar N. Triglycerides and coronary heart disease: have recent insights yielded conclusive answers?. Curr Opin Lipidol 2009, 20:275-281.
3. Staff A.C., Dechend R., Pijnenborg R. Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension 2010, 56:1026-1034.
4. Dayspring T.D. Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters. Int J Womens Health 2011, 3:87-97.
5. Solhpour A., Parkhideh S., Sarrafzadegan N., Asgary S., Williams K., Jungner I., et al. Levels of lipids and apolipoproteins in three cultures. Atherosclerosis 2009, 207:200-207.
6. Wiznitzer A., Mayer A., Novack V., Sheiner E., Gilutz H., Malhotra A., et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 2009, 201. 482.e1-488.e1.
7. Ray J.G., Diamond P., Singh G., Bell C.M. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 2006, 113:379-386.
8. Craici I.M., Wagner S.J., Hayman S.R., Garovic V.D. Pre-eclamptic pregnancies: an opportunity to identify women at risk for future cardiovascular disease. Womens Health (Lond Engl) 2008, 4:133-135.
9. Golden S.H., Bennett W.L., Baptist-Roberts K., Wilson L.M., Barone B., Gary T.L., et al. Antepartum glucose tolerance test results as predictors of type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: a systematic review. Gend Med 2009, 6(Suppl 1):109-122.
10. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996, 3:213-219.
11. Mazza A., Tikhonoff V., Schiavon L., Casiglia E. Triglycerides + high-density lipoprotein- cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly. Intern Med J 2005, 35:604-610.
12. Arsenault B.J., Rana J.S., Stroes E.S., Després J.P., Shah P.K., Kastelein J.J., et al. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol 2009, 55:35-41.
13. Di Angelantonio E., Sarwar N., Perry P., Kaptoge S., Ray K.K., Thompson A., et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009, 302:1993-2000. Emerging Risk Factors Collaboration.
14. Rich-Edwards J.W., McElrath T.F., Karumanchi S.A., Seely E.W. Breathing life into the life course approach: Pregnancy history and cardiovascular disease in women. Hypertension 2010, 56:331-334.
15. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Vital Health Stat 1994, 1:1-407. National Center for Health Statistics.
16. Centers for Disease Control and Prevention: National Center for Health Statistics. Research Ethics Review Board approval. Available at: Accessed May 11, 2010. http://www.cdc.gov/nchs/nhanes/irba98.htm.
17. National Center for Health Statistics. Office of Analysis and Epidemiology, the Third National Health and Nutrition Examination Survey (NHANES III) linked mortality file. Mortality follow-up through 2006: matching methodology. Hyattsville, MD: NCHS; May 2009. Available at: Accessed May 11, 2010. http://www.cdc.gov/nchs/data/datalinkage/matching_methodology_nhanes3_final.pdf.
18. Kriska A.M., Edelstein S.L., Hamman R.F., Otto A., Bray G.A., Mayer-Davis E.J., et al. Physical activity in individuals at risk for diabetes: Diabetes Prevention Program. Med Sci Sports Exerc 2006, 38:826-832.
19. Tomar S.L., Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 2000, 71:743-751.
20. Kennedy E.T., Ohls J., Carlson S., Fleming K. The Healthy Eating Index: design and applications. J Am Diet Assoc 1995, 95:1103-1108.
21. Hingorani A.D., Shah T., Casas J.P., Humphries S.E., Talmud P.J. C-reactive protein and coronary heart disease: predictive test or therapeutic target?. Clin Chem 2009, 55:239-255.
22. NHANES III reference manuals and reports (CD-ROM) 1996, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
23. Carroll M.D., Lacher D.A., Sorlie P.D., Cleeman J.I., Gordon D.J., Wolz M., et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005, 294:1773-1781.
24. Kuklina E.V., Yoon P.W., Keenan N.L. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. JAMA 2009, 302:2104-2110.
25. Anderson RN, Miniño AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD -9 and ICD -10: Preliminary estimates. Natl Vital Stat Rep. 2001;49(2). Hyattsville, Maryland: National Center for Health Statistics. 2001.
26. NHANES III: Linked mortality files citation list as of 02/24/2010. Available at: Accessed May 11, 2010. http://www.cdc.gov/nchs/data/datalinkage/nhanes3_mort_cit_list.pdf.
27. Sieri S., Krogh V., Berrino F., Evangelista A., Agnoli C., Brighenti F., et al. Dietary glycemic load and index and risk of coronary heart disease in a large Italian cohort: the EPICOR study. Arch Intern Med 2010, 170:640-647.
28. Dale K.M., Coleman C.I., Shah S.A., Patel A.A., Kluger J., White C.M. Impact of gender on statin efficacy. Curr Med Res Opin 2007, 23:640-647.
29. El-Khairy L., Vollset S.E., Refsum H., Ueland P.M. Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study. Clin Chem 2003, 49:113-120.